Rachel Sarah Dada, MD

Articles by Rachel Sarah Dada, MD

Mortality Risk Stratification Can Predict Readmissions but Not Length of Stay

ByAnupam Ashutosh Sule, MD, PhD,Rachel Sarah Dada, MD,Jafar Dada, MD

February 10th 2021

Mortality risk stratification can identify patients at higher risk of mortality and readmissions for prevention strategies. Other patients should be the focus of length-of-stay reduction strategies.

Latest Updated Articles

Mortality Risk Stratification Can Predict Readmissions but Not Length of Stay
February 10th 2021

Rachel Sarah Dada, MD

Articles by Rachel Sarah Dada, MD

Mortality Risk Stratification Can Predict Readmissions but Not Length of Stay

Latest Updated Articles

Trending on AJMC

Medicare Part D Ruxolitinib Spending Hits $49.6 Million as Use Surges

Surrogate End Points, Drug Costs Complicate Oncology Formularies

COVID-19 or Flu? Symptoms Alone Can't Tell: Tammy Lundstrom, MD, JD

Perceptions About CGMs Among Primary Care Physicians and Endocrinologists

Peptide Regulation Debate Intensifies After FDA Advisory Panel's Controversial Vote

Building a Cellular Therapy Program in the Community Oncology Setting: Perspectives and Lessons Learned

Rachel Sarah Dada, MD

Articles by Rachel Sarah Dada, MD

Mortality Risk Stratification Can Predict Readmissions but Not Length of Stay

Latest Updated Articles

Trending on AJMC

Medicare Part D Ruxolitinib Spending Hits $49.6 Million as Use Surges

Surrogate End Points, Drug Costs Complicate Oncology Formularies

COVID-19 or Flu? Symptoms Alone Can't Tell: Tammy Lundstrom, MD, JD

Perceptions About CGMs Among Primary Care Physicians and Endocrinologists

Peptide Regulation Debate Intensifies After FDA Advisory Panel's Controversial Vote